Association between BRCA mutations and endometrial carcinoma: a systematic review with meta-analysis

被引:0
作者
Guojiao Lu
Tao Lu
Jichen Pan
Ling Guo
Yingxin Pang
Peishu Liu
机构
[1] Qilu Hospital of Shandong University,Department of Obstetrics and Gynecology
来源
Archives of Gynecology and Obstetrics | 2021年 / 303卷
关键词
Endometrial carcinoma; BRCA mutations; Tamoxifen; Prophylactic hysterectomy; BSO; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1569 / 1579
页数:10
相关论文
共 116 条
[1]  
Benito V(2009)Pure papillary serous tumors of the endometrium: a clinicopathological analysis of 61 cases from a single institution Int J Gynecol Cancer 19 1364-1369
[2]  
Lubrano A(2018)Cancer statistics for hispanics/latinos, 2018 CA Cancer J Clin 68 425-445
[3]  
Arencibia O(1999)Is uterine serous papillary carcinoma a BRCA1-related disease? case report and review of the literature Gynecol Oncol 75 300-304
[4]  
Miller KD(1983)Two pathogenetic types of endometrial carcinoma Gynecol Oncol 15 10-17
[5]  
Goding Sauer A(2010)Molecular profiling of endometrial malignancies Obstet Gynecol Int 2010 162363-580
[6]  
Ortiz AP(2018)Endometrial cancer: Molecular markers and management of advanced stage disease Gynecol Oncol 150 569-362
[7]  
Hornreich G(2006)Adjuvant therapy for patients with stage I papillary serous endometrial cancer Eur J Surg Oncol 32 358-661
[8]  
Beller U(2012)Uterine papillary serous cancer: a review of the literature Gynecol Oncol 127 651-232
[9]  
Lavie O(1997)A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses Verh Dtsch Ges Pathol 81 228-481
[10]  
Bokhman JV(2013)An immunohistochemical panel to distinguish ovarian from uterine serous papillary carcinomas Int J Gynecol Pathol 32 476-6